Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease

Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease

Item
http://www.wikidata.org/entity/Q27696305
Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946)Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical developmentThe Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation.Puquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemiaStructural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase δRevealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental ValidationEffect of Glycyrrhiza on the Diuretic Function of Euphorbia kansui: An Ascites Mouse ModelDesign, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors.PI3K signaling in cancer: beyond AKT.Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia.Switchable highly regioselective synthesis of 3,4-dihydroquinoxalin-2(1H)ones from o-phenylenediamines and aroylpyruvates.Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors.PI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma.Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma.Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib
P2860

Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease

Item
http://www.wikidata.org/entity/Q27696305
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@ast
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@en
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@nl
type
label
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@ast
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@en
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@nl
prefLabel
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@ast
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@en
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@nl
P1433
P1476
P2093
P304
P31
P3181
P356
P407
P433
P478
P577
P698
P921
P3181
P356
P1433
P1476
Discovery and in vivo evaluati ...... mmation and autoimmune disease
@en
P2093
P304
P31
P3181
P356
P407
P433
P478
P577
P698
P921